late-onset Alzheimer's disease
GPTKB entity
Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:psychologist
|
| gptkbp:affects |
older adults
|
| gptkbp:clinical_trial |
anti-amyloid therapies
anti-tau therapies |
| gptkbp:current_use |
gptkb:historical_event
vascular dementia |
| gptkbp:genetic_diversity |
gptkb:APOE_ε4_allele
|
| gptkbp:has_ability |
declines over time
|
| https://www.w3.org/2000/01/rdf-schema#label |
late-onset Alzheimer's disease
|
| gptkbp:impact |
gptkb:healthcare_organization
caregivers |
| gptkbp:is_involved_in |
gptkb:Alzheimer's_Association
gptkb:Alzheimer's_Society |
| gptkbp:is_popular_in |
most common form of dementia
|
| gptkbp:number_of_stages |
moderate
mild severe |
| gptkbp:number_of_teams |
gradual
|
| gptkbp:public_awareness |
gptkb:World_Alzheimer's_Day
Alzheimer's Awareness Month |
| gptkbp:research |
amyloid plaques
tau tangles neuroinflammation oxidative stress |
| gptkbp:research_focus |
environmental factors
biomarkers genetic factors |
| gptkbp:risk_factor |
gptkb:hospital
gptkb:Company social isolation age obesity family history smoking head trauma low education level |
| gptkbp:social_responsibility |
gptkb:DSM-5
clinical assessment cognitive tests neuropsychological testing neuroimaging NINCDS-ADRDA |
| gptkbp:symptoms |
cognitive decline
memory loss lifestyle changes medication management disorientation difficulty with language |
| gptkbp:treatment |
improve quality of life
medications cholinesterase inhibitors antidepressants antipsychotics cognitive therapies slow progression NMDA receptor antagonists |
| gptkbp:type_of_care |
counseling services
palliative care support groups education programs supportive care respite care |
| gptkbp:bfsParent |
gptkb:APOE_ε4_allele
|
| gptkbp:bfsLayer |
8
|